Lucie Hejnová , Stanislav Tuček , Esam E. El-Fakahany
{"title":"Positive and negative allosteric interactions on muscarinic receptors","authors":"Lucie Hejnová , Stanislav Tuček , Esam E. El-Fakahany","doi":"10.1016/0922-4106(95)90085-3","DOIUrl":null,"url":null,"abstract":"<div><p>It was previously found that alcuronium increases the binding of [<sup>3</sup>H]methyl-<em>N</em>-scopolamine to cardiac muscarinic receptors by a positive allosteric action while its effect on the binding of [<sup>3</sup>H]quinuclildinyl benzilate is negative. The features of the antagonit's molecule which decide whether its allosteric interaction with alcuronium is positive or negative are not known. In the present work, it was found that alcuronium has a positive allosteric effect also on the binding [<sup>3</sup>H]atropine and [<sup>3</sup>H]methyl-<em>N</em>-piperidinyl benzilate to muscarinic receptors in rat heart atria and that its effect on the binding of [<sup>3</sup>H]methyl-<em>N</em>-quinuclidinyl benzilate is negative. A comparison of the five radiolabelld antagonists that have been investigated so far indicates that the type of allosteric interaction (positive or negative) is not determined by the presence or absence of the quaternary nitrogen or of the benzilyl moiety in the molecule of the antagonist. Apparently, features of the <em>N</em>-bearing moiety of muscarinic antagonists other than the presence of a charge on nitrogen play a key role in the determination of the type of interaction.</p></div>","PeriodicalId":100502,"journal":{"name":"European Journal of Pharmacology: Molecular Pharmacology","volume":"291 3","pages":"Pages 427-430"},"PeriodicalIF":0.0000,"publicationDate":"1995-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0922-4106(95)90085-3","citationCount":"32","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmacology: Molecular Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0922410695900853","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32
Abstract
It was previously found that alcuronium increases the binding of [3H]methyl-N-scopolamine to cardiac muscarinic receptors by a positive allosteric action while its effect on the binding of [3H]quinuclildinyl benzilate is negative. The features of the antagonit's molecule which decide whether its allosteric interaction with alcuronium is positive or negative are not known. In the present work, it was found that alcuronium has a positive allosteric effect also on the binding [3H]atropine and [3H]methyl-N-piperidinyl benzilate to muscarinic receptors in rat heart atria and that its effect on the binding of [3H]methyl-N-quinuclidinyl benzilate is negative. A comparison of the five radiolabelld antagonists that have been investigated so far indicates that the type of allosteric interaction (positive or negative) is not determined by the presence or absence of the quaternary nitrogen or of the benzilyl moiety in the molecule of the antagonist. Apparently, features of the N-bearing moiety of muscarinic antagonists other than the presence of a charge on nitrogen play a key role in the determination of the type of interaction.
先前研究发现,alcuronium通过正变构作用增加[3H]甲基- n -东莨菪碱与心脏毒蕈碱受体的结合,而对[3H]喹啉苄基苯甲酸盐的结合则是负作用。拮抗剂分子的特性决定了其与铝矾铵的变构相互作用是正的还是负的,目前还不清楚。本研究发现,阿库溴铵对[3H]阿托品和[3H]甲基- n -哌啶苄基苯磺酸盐与大鼠心房毒蕈碱受体的结合也有正变构作用,对[3H]甲基- n -喹啶苄基苯磺酸盐的结合作用为负变构作用。对目前已研究的五种放射性标签拮抗剂的比较表明,变构相互作用的类型(正或负)不是由拮抗剂分子中是否存在季氮或苄基部分决定的。显然,除氮上是否带电外,毒蕈碱拮抗剂含氮部分的特征在确定相互作用类型方面起着关键作用。